Research Study

Past Study: GIO B

Study Status: CLOSED

Study Name: GIO-B

Study Focus:   Obesity

 

Study Contact: To learn more, please call 1-877-854-8475 or fill out the Contact us form.

Study Purpose:  Is to assess the effects of a continuous infusion (over 72 hours) of glucagon (FDA approved, however the dosage of the glucagon has not been FDA approved) to measure energy in Healthy Obese Subjects.  The current study is to measure energy while you are resting, sleeping and exercising in our Metabolic chamber (a special room where we measure energy).

To be enrolled in this study, you must meet certain requirements. You are eligible to participate in one of the following groups if you meet the associated criteria:

  • Healthy, men and women without diabetes
  • Ages 18 – 55
  • BMI greater than or equal to 27 and Less than or equal to 45 kg/m2 and body weight < 450 lbs

Study Duration:  up to 5 weeks

Study Commitment: The study consists of 2 outpatient visits, 6 Inpatient days and 1 follow up visit.

  • 1 Screening visit
  • 1 Outpatient visit Study Day -5, Inpatient visit Study Day -2 thru Study Day 4 (approx.6 days), follow up visit 2-5 days after discharge from the CRU.

Study Procedures:

  • Physical exam, vital signs, height, and weight
  • IV insertion for Glucagon infusion and blood draws
  • Dual Energy X-ray Absorptiometry (DEXA) to measure body composition
  • Metabolic chamber (special room where we measure energy)
  • Questionnaires

Compensation offered? Yes

This study is being conducted under the direction of Dr. Steven Smith, at 301 East Princeton Street, Orlando, Florida 32804.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

.